Notice to Convene the Annual General Meeting of Genmab A/S Company Announcement Genmab A/S to hold Annual General Meeting on Thursday March 19, 2026 COPENHAGEN, Denmark; February 18, 2026 – (Nasdaq: GMAB) summons the Annual General Meeting on Thursday, March 19, 2026, at 2:00 PM CET at the Copenhagen Marriott Hotel, Kalvebod Brygge 5, DK-1560 Copenhagen V, Denmark. The notice for the Annual General Meeting, including Appendix 1: Candidates for the Board of Directors, is attached. About Genmab Genmab is an international biotechnology company dedicated to improving the lives of people ...
Genmab Announces Initiation of Share Buy-Back Program Company Announcement Repurchase of up to 342,130 shares with a maximum aggregate total value of 725 million DKK Honoring our commitments under the Restricted Stock Unit programCompletion expected no later than March 31, 2026 COPENHAGEN, Denmark; February 17, 2026 – (Nasdaq: GMAB) announced today that it is initiating a share buy-back program, to honor our commitments under the Restricted Stock Unit program. The share buy-back program will be undertaken on the terms set out below and in accordance with Regulation (EU) No. 596/2014 (‘M...
Genmab Files Annual Report with the U.S. Securities and Exchange Commission Media ReleaseCOPENHAGEN, Denmark; February 17, 2026 Genmab filed Form 20-F for the financial year 2025 with the U.S. SEC (Nasdaq: GMAB) announced today that it has filed its Annual Report for the financial year 2025 on Form 20-F with the U.S. Securities and Exchange Commission (SEC), incorporating by reference parts of the Genmab A/S Annual Report 2025. Both reports are available via the SEC’s website, and Genmab’s website, . About Genmab Genmab is an international biotechnology company dedicated to improving t...
Genmab Publishes 2025 Annual Report Company Announcement COPENHAGEN, Denmark; February 17, 2026 – (Nasdaq: GMAB) announced today the publication of its Annual Report for 2025. Below is a summary of business progress in 2025, financial performance for the year and the financial outlook for 2026. The full report is attached as a PDF file and in iXBRL format and can be found in the investor section of the company’s website, . Conference CallGenmab will hold a conference call to discuss the full year results for 2025 today, February 17, 2026 at 6:00 pm CET, 5:00 pm GMT, 12:00 pm EST. To join...
A record fourth quarter ends a record year for Mowi (Bergen, 11 February 2026) Mowi reported record-high revenues of EUR 1.59 billion and operational EBIT of EUR 213 million in the fourth quarter. Mowi ended 2025 by once again setting a number of new records, both for the fourth quarter and for the full year. Norway’s largest food producer and the world’s largest salmon farmer has never had better revenues or harvest volumes than in 2025, with turnover of EUR 5.73 billion and harvest volumes of 559,000 tonnes, equivalent to annual growth of 11.4%. At 152,000 tonnes, volumes in the fourth q...
Mowi ASA (OSE: MOWI): Quarterly dividend The Board of Mowi ASA has resolved on 10 February 2026 to make a quarterly distribution to shareholders of NOK 1.50 per share. Mowi ASA’s shares listed on the Oslo Stock Exchange will be traded including dividend up to and including 19 February 2026. Mowi ASA’s shares listed on the Oslo Stock Exchange will be traded excluding dividend from and including 20 February 2026. Mowi ASA’s shares listed on the Oslo Stock Exchange will have a Record Date of 23 February 2026. The expected payment date is 2 March 2026. This information is subject to the discl...
Rekordkvartal avsluttet rekordår for Mowi (Bergen, 11. februar 2026) Mowi rapporterte rekordhøye inntekter på 1,59 milliarder euro (18,7 milliarder kroner) og et operasjonelt driftsresultat på 213 millioner euro (2,5 milliarder kroner) i fjerde kvartal. Mowi avsluttet 2025 med en rekke rekorder, både i fjerde kvartal og for året som helhet. Norges største matprodusent og verdens største lakseoppdretter har aldri hatt høyere inntekter og slaktevolumer i et år enn det hadde i fjor, med omsetning på 5,73 milliarder euro (67 milliarder kroner) og slaktevolum på 559 000 tonn, som tilsvarer en å...
Mowi ASA (OSE:MOWI): Presentation of Q4 2025 results 11 February 2026 at 08:00 (CET) Mowi ASA hereby invites you to the presentation of the results for the fourth quarter 2025 at The Salmon, Strandpromenaden 11, 0252 Oslo, Norway. The results will be presented in English through a live webcast followed by a Q&A session. Participants will have the opportunity to submit questions online throughout the webcast session. The webcast will be available on A recording of the webcast will be made available on our website immediately afterwards. Please note that the quarterly report and pre...
Grant of Restricted Stock Units and Warrants to Employees in Genmab Company Announcement COPENHAGEN, Denmark; January 29, 2026 – (Nasdaq: GMAB) announced today that the Board of Directors decided to grant 32,806 restricted stock units and 34,307 warrants to employees of the Company and the Company's subsidiaries. Each restricted stock unit is awarded cost-free and provides the owner with a conditional right to receive one share in Genmab A/S of nominally DKK 1. The fair value of each restricted stock unit is equal to the closing market price on the date of grant of one Genmab A/S share, ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.